Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Berk

Showing results (911-920 of 1,136) with videos related to

Pageof 114
Sort By:
Journal of Affective Disorders|June 13, 2016
A cluster analytic approach to identifying predictors and moderators of psychosocial treatment for bipolar depression: Results from STEP-BDThilo Deckersbach, Amy T Peters, Louisa G Sylvia, et al.
Journal of Affective Disorders|July 16, 2017
Indices of insulin resistance and glucotoxicity are not associated with bipolar disorder or major depressive disorder, but are differently associated with inflammatory, oxidative and nitrosative biomarkersKamila Landucci Bonifácio, Décio Sabbatini Barbosa, Estefânia Gastaldello Moreira, et al.
BMC Psychiatry|May 18, 2024
A randomized controlled trial to compare the effects of time-restricted eating versus Mediterranean diet on symptoms and quality of life in bipolar disorderSheri L Johnson, Greg Murray, Lance J Kriegsfeld, et al.
Trials|April 10, 2019
Protocol update and statistical analysis plan for CADENCE-BZ: a randomized clinical trial to assess the efficacy of sodium benzoate as an adjunctive treatment in early psychosisCarmen Lim, Andrea Baker, Sukanta Saha, et al.
International Psychogeriatrics|September 3, 2016
ASPREE-D: Aspirin for the prevention of depression in the elderlyMichael Berk, R L Woods, M R Nelson, et al.
The Journal of Clinical Psychiatry|July 9, 2014
The efficacy of adjunctive N-acetylcysteine in major depressive disorder: a double-blind, randomized, placebo-controlled trialMichael Berk, Olivia M Dean, Sue M Cotton, et al.
Acta Psychiatrica Scandinavica|January 16, 2023
Childhood trauma and depressive symptoms in bipolar disorder: A network analysisAnna L Wrobel, Sue M Cotton, Anuradhi Jayasinghe, et al.
Neurotoxicity Research|November 3, 2023
Metergoline Shares Properties with Atypical Antipsychotic Drugs Identified by Gene Expression Signature ScreenChiara C Bortolasci, Emily J Jaehne, Damián Hernández, et al.
Psychotherapy and Psychosomatics|September 4, 2019
International Society for Nutritional Psychiatry Research Practice Guidelines for Omega-3 Fatty Acids in the Treatment of Major Depressive DisorderTa-Wei Guu, David Mischoulon, Jerome Sarris, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|February 18, 2021
Plant-based Medicines (Phytoceuticals) in the Treatment of Psychiatric Disorders: A Meta-review of Meta-analyses of Randomized Controlled Trials: Les médicaments à base de plantes (phytoceutiques) dans le traitement des troubles psychiatriques: une méta-revue des méta-analyses d'essais randomisés contrôlésJerome Sarris, Wolfgang Marx, Melanie M Ashton, et al.
Pageof 114

Showing results (911-920 of 1,136) with videos related to

Sort By:
Pageof 114
Journal of Affective Disorders|June 13, 2016
A cluster analytic approach to identifying predictors and moderators of psychosocial treatment for bipolar depression: Results from STEP-BDThilo Deckersbach, Amy T Peters, Louisa G Sylvia, et al.
Journal of Affective Disorders|July 16, 2017
Indices of insulin resistance and glucotoxicity are not associated with bipolar disorder or major depressive disorder, but are differently associated with inflammatory, oxidative and nitrosative biomarkersKamila Landucci Bonifácio, Décio Sabbatini Barbosa, Estefânia Gastaldello Moreira, et al.
BMC Psychiatry|May 18, 2024
A randomized controlled trial to compare the effects of time-restricted eating versus Mediterranean diet on symptoms and quality of life in bipolar disorderSheri L Johnson, Greg Murray, Lance J Kriegsfeld, et al.
Trials|April 10, 2019
Protocol update and statistical analysis plan for CADENCE-BZ: a randomized clinical trial to assess the efficacy of sodium benzoate as an adjunctive treatment in early psychosisCarmen Lim, Andrea Baker, Sukanta Saha, et al.
International Psychogeriatrics|September 3, 2016
ASPREE-D: Aspirin for the prevention of depression in the elderlyMichael Berk, R L Woods, M R Nelson, et al.
The Journal of Clinical Psychiatry|July 9, 2014
The efficacy of adjunctive N-acetylcysteine in major depressive disorder: a double-blind, randomized, placebo-controlled trialMichael Berk, Olivia M Dean, Sue M Cotton, et al.
Acta Psychiatrica Scandinavica|January 16, 2023
Childhood trauma and depressive symptoms in bipolar disorder: A network analysisAnna L Wrobel, Sue M Cotton, Anuradhi Jayasinghe, et al.
Neurotoxicity Research|November 3, 2023
Metergoline Shares Properties with Atypical Antipsychotic Drugs Identified by Gene Expression Signature ScreenChiara C Bortolasci, Emily J Jaehne, Damián Hernández, et al.
Psychotherapy and Psychosomatics|September 4, 2019
International Society for Nutritional Psychiatry Research Practice Guidelines for Omega-3 Fatty Acids in the Treatment of Major Depressive DisorderTa-Wei Guu, David Mischoulon, Jerome Sarris, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|February 18, 2021
Plant-based Medicines (Phytoceuticals) in the Treatment of Psychiatric Disorders: A Meta-review of Meta-analyses of Randomized Controlled Trials: Les médicaments à base de plantes (phytoceutiques) dans le traitement des troubles psychiatriques: une méta-revue des méta-analyses d'essais randomisés contrôlésJerome Sarris, Wolfgang Marx, Melanie M Ashton, et al.
Pageof 114